Medical laser technology developer Quantel Medical (Les Ulis, France), a subsidiary of the Lumibird Group (Lannion, France), has acquired Optotek Medical (Ljubljana, Slovenia), which specializes in developing optical and laser solutions for medical applications. This acquisition marks the culmination of the longstanding collaboration established between the two companies through OEM contracts to develop and supply devices for Quantel Medical's range of anterior chamber lasers for the treatment of secondary cataracts and glaucoma.
The acquisition will also enable Quantel Medical to further strengthen its R&D expertise for medical lasers and its industrial integration with an additional ISO 13485-certified production unit based in Ljubljana.
Optotek Medical's revenues came to €6.6 million (over $7.3 million) in 2018. Nearly two thirds were recorded with Quantel Medical, with the balance generated on a range of ophthalmic lasers sold in around 30 countries. Optotek has built up advanced optics and micromechanical expertise.
With the acquisition, Quantel Medical is also expanding its selection of OEM solutions for markets such as dermatology or ear, nose, and throat (ENT) surgery with articulated arms, according to Marc Le Flohic, Lumibird's Chairman and CEO.
For more information, please visit lumibird.com and optotek-medical.com.